**Specifications Table**TableSubject area*Biology, Psychology*More specific subject area*Psychopharmacology*Type of data*Excel file*How data was acquired*Aluminum operant chambers measuring 26 cm*×*26 cm*×*26 cm (Med Associates Inc., St. Albans, VT, USA) were used.*Data format*Raw*Experimental factors*Nicotine and/or varenicline administration*Experimental features*Adult male Wistar/ST rats were used.*Data source location*N/A*Data accessibility*All data were presented here.*

**Value of the data**•The effects of stop-smoking aids on cognitive functions were of interest to many people.•Some researchers might be interested in some parameters we did not focus on in the research paper [@bib1].•Clinicians can design human studies based on the animal data.•The raw data would be useful if one would like to conduct reanalysis or meta-analysis.

1. Data {#s0005}
=======

[Data file 1](#s0030){ref-type="sec"} contains the raw data regarding Fig. 1 in [@bib1]: several parameters (see below, [Section 2](#s0010){ref-type="sec"}) in a 3-choice serial reaction time task (3-CSRTT) in nicotine-naïve rats. [Data file 2](#s0030){ref-type="sec"} contains the raw data regarding Fig. 2 in [@bib1]: several parameters in the 3-CSRTT in nicotine-naïve rats after varenicline administration followed by microinjection of a α4β2 nicotinic acetylcholine receptor antagonist into the infralimbic cortex (IL). [Data file 3](#s0030){ref-type="sec"} contains the raw data regarding Fig. 3 in [@bib1]: several parameters in the 3-CSRTT in nicotine-naïve rats after acute s.c. injection of nicotine and varenicline. [Data file 4](#s0030){ref-type="sec"} contains the raw data regarding Figs. 4 and 5 in [@bib1]: several parameters in the 3-CSRTT after continuous infusion of nicotine and acute/repeated oral administration of varenicline.

2. Experimental design, materials and methods {#s0010}
=============================================

We used a 3-choice serial reaction time task to assess impulsivity and other cognitive functions in rats [@bib1]. We recorded seven behavioral parameters, as described below.(a)Premature responses (counts per session): a measure of impulsivity.(b)Accuracy (percentage of correct responses): a measure of attentional function.(c)Omissions (counts per session): a measure of attentional function and motivation.(d)Perseverative responses (counts per session): a measure of compulsivity.(e)Responses during time-out (counts per session): a measure of motivation and motor activity.(f)Correct response latency(s): a measure of attentional function, motivation, motor function, and decision time.(g)Reward latency (s): a measure of motivation and motor function.

As for [data file 1](#s0030){ref-type="sec"}, nicotine naïve rats received acute s.c. injection of varenicline (0, 0.0075, 0.075, and 0.75 mg/kg) 60 min before the testing session.

As for [data file 2](#s0030){ref-type="sec"}, nicotine naïve rats received acute s.c. injection of varenicline (0 and 0.075 mg/kg) 60 min before the testing session and intra-IL microinjection of dihydro-β-erythroidine (DHβE; 0 and 6 μg/side), a preferential α4β2 nAChR antagonist, 10 min before the testing session.

As for [data file 3](#s0030){ref-type="sec"}, nicotine naïve rats received acute s.c. injection of varenicline (0, 0.0075, 0.075, and 0.75 mg/kg, s.c.) 60 min before the testing session and acute s.c. injection of nicotine (0 and 0.2 mg/kg) 10 min before the testing session. The dose of nicotine was the same as that used in our previous studies, demonstrating that nicotine induced impulsive action [@bib2], [@bib3].

As for [data file 4](#s0030){ref-type="sec"}, rats received acute oral administration of varenicline (0.075 mg/kg) 60 min before the testing session after 8 days of continuous nicotine (9 mg/kg/day, salt) or sodium tartrate administration with osmotic minipumps. The blood concentrations resulting from this dose in rats are comparable to those measured in heavy smokers [@bib4], [@bib5]. Repeated oral administration of varenicline (0.075 mg/kg, once per day) was conducted after stopping continuous nicotine infusion.
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